A bipartite interaction with the processivity clamp potentiates Pol IV-mediated TLS
Abstract
Processivity clamps mediate polymerase switching for translesion synthesis (TLS). All three Escherichia coli TLS polymerases interact with the β 2 processivity clamp through a conserved clamp-binding motif (CBM), which is indispensable for TLS. Notably, Pol IV also interacts weakly with the rim of the clamp through non-CBM residues. Ablating this “rim contact” in cells results in selective sensitivity to DNA-damaging agents, raising the question how the rim contact contributes to TLS. Here, we show that the rim contact is critical for TLS past a strong replication block but barely necessary for a weak blocking lesion. Within the in vitro reconstituted E. coli replisome, the rim mutation compromises Pol IV-mediated TLS past 3-deaza-methyl dA, a strong block, whereas barely affecting TLS past N 2 -furfuryl dG, a weak block. Similar observations are also made in E. coli cells bearing a single copy of these lesions in the genome. At lesion-stalled replication forks, single-stranded DNA binding protein locally enriches Pol IV, enabling it to bind the low-affinity rim site. This interaction poises Pol IV to better compete with Pol III, the replicative polymerase, which competitively inhibits Pol IV from interacting with the clamp through its CBM. We propose that this bipartite clamp interaction enables Pol IV to rapidly resolve lesion-stalled replication at a strong block through TLS, which reduces damage-induced mutagenesis.
Article Details
Journal Info
Proceedings of the National Academy of Sciences
National Academy of Sciences
Authors (8)
Seungwoo Chang
Department of Biological Chemistry and Molecular Pharmacology, Blavatnik Institute, Harvard Medical School
Luisa Laureti
Cancer Research Center of Marseille: Team DNA Damage and Genome Instability|CNRS, Inserm, Institut Paoli-Calmettes, Aix Marseille Université
Elizabeth S. Thrall
Department of Biological Chemistry and Molecular Pharmacology, Blavatnik Institute, Harvard Medical School
Marguerite S. Kay
Department of Biological Chemistry and Molecular Pharmacology, Blavatnik Institute, Harvard Medical School
Gaëlle Philippin
Cancer Research Center of Marseille: Team DNA Damage and Genome Instability|CNRS, Inserm, Institut Paoli-Calmettes, Aix Marseille Université
Slobodan Jergic
School of Chemistry and Molecular Bioscience, Molecular Horizons, University of Wollongong
Vincent Pagès
Cancer Research Center of Marseille: Team DNA Damage and Genome Instability|CNRS, Inserm, Institut Paoli-Calmettes, Aix Marseille Université
Joseph J. Loparo
Department of Biological Chemistry and Molecular Pharmacology, Blavatnik Institute, Harvard Medical School